Skip to main content
. 2015 May 15;8(5):6735–6742.

Figure 2.

Figure 2

Comparison of Serum IL-17A Concentration in Each Group at 30th day (X̅ ± s). Notes: 1. *P < 0.05 compared to normal control group; 2. ΔP < 0.05 compared to model control group; 3. ○P < 0.05 compared to low-dose group; 4. ☆P < 0.05 compared to lamivudine group.